Medical Care
Global Synthetic Blood Substitutes and Blood Product Market Research Report 2025
- Mar 11, 25
- ID: 20491
- Pages: 99
- Figures: 105
- Views: 1
The global market for Synthetic Blood Substitutes and Blood Product was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Artificial blood replacement in the human body is referred to as synthetic blood substitutes. A blood replacement is a substance that is utilised to meet the biological needs of the body that are not met by real blood. A set of chemicals made consisting of carbon and fluorine are used to create artificial blood. These molecules may dissolve 50 times more oxygen into the body than blood plasma. Internally, the molecules work similarly to blood, supplying oxygen to different regions of the body, organs, and tissues.Patients suffer massive blood loss as a result of catastrophic injuries and diseases, resulting in the deaths of thousands of patients each year. Fresh blood also has a 42-hour life span. Because of this obstacle, synthetic blood substitutes are required to meet the patient"s immediate blood supply needs and to extend his or her life.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Synthetic Blood Substitutes and Blood Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Synthetic Blood Substitutes and Blood Product.
The Synthetic Blood Substitutes and Blood Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Synthetic Blood Substitutes and Blood Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Synthetic Blood Substitutes and Blood Product manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Aurum Biosciences Ltd
Hemarina SA
KaloCyte Inc.
NuvOx Pharma LLC
Northfield Laboratories
Dentritech, Inc.
HemoBioTech, Inc.
Dextro-Sang Corp.
Baxter International
FluorO2 Therapeutics
Alpha Therapeutic Corp.
Hemoglobin Oxygen Therapeutics LLC
SpheriTech Ltd
Sangart, Inc.
BioPure
PHORNANO Holding GmbH
Segment by Type
Human Blood
Animal Blood
Microorganisms
Synthetic Polymers
Stem Cells
Others
Segment by Application
Hospitals and Clinics
Blood Banks
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Synthetic Blood Substitutes and Blood Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Synthetic Blood Substitutes and Blood Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Artificial blood replacement in the human body is referred to as synthetic blood substitutes. A blood replacement is a substance that is utilised to meet the biological needs of the body that are not met by real blood. A set of chemicals made consisting of carbon and fluorine are used to create artificial blood. These molecules may dissolve 50 times more oxygen into the body than blood plasma. Internally, the molecules work similarly to blood, supplying oxygen to different regions of the body, organs, and tissues.Patients suffer massive blood loss as a result of catastrophic injuries and diseases, resulting in the deaths of thousands of patients each year. Fresh blood also has a 42-hour life span. Because of this obstacle, synthetic blood substitutes are required to meet the patient"s immediate blood supply needs and to extend his or her life.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Synthetic Blood Substitutes and Blood Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Synthetic Blood Substitutes and Blood Product.
The Synthetic Blood Substitutes and Blood Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Synthetic Blood Substitutes and Blood Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Synthetic Blood Substitutes and Blood Product manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Aurum Biosciences Ltd
Hemarina SA
KaloCyte Inc.
NuvOx Pharma LLC
Northfield Laboratories
Dentritech, Inc.
HemoBioTech, Inc.
Dextro-Sang Corp.
Baxter International
FluorO2 Therapeutics
Alpha Therapeutic Corp.
Hemoglobin Oxygen Therapeutics LLC
SpheriTech Ltd
Sangart, Inc.
BioPure
PHORNANO Holding GmbH
Segment by Type
Human Blood
Animal Blood
Microorganisms
Synthetic Polymers
Stem Cells
Others
Segment by Application
Hospitals and Clinics
Blood Banks
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Synthetic Blood Substitutes and Blood Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Synthetic Blood Substitutes and Blood Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Synthetic Blood Substitutes and Blood Product Market Overview
1.1 Product Definition
1.2 Synthetic Blood Substitutes and Blood Product by Type
1.2.1 Global Synthetic Blood Substitutes and Blood Product Market Value Comparison by Type (2024 VS 2031)
1.2.2 Human Blood
1.2.3 Animal Blood
1.2.4 Microorganisms
1.2.5 Synthetic Polymers
1.2.6 Stem Cells
1.2.7 Others
1.3 Synthetic Blood Substitutes and Blood Product by Application
1.3.1 Global Synthetic Blood Substitutes and Blood Product Market Value by Application (2024 VS 2031)
1.3.2 Hospitals and Clinics
1.3.3 Blood Banks
1.3.4 Others
1.4 Global Synthetic Blood Substitutes and Blood Product Market Size Estimates and Forecasts
1.4.1 Global Synthetic Blood Substitutes and Blood Product Revenue 2020-2031
1.4.2 Global Synthetic Blood Substitutes and Blood Product Sales 2020-2031
1.4.3 Global Synthetic Blood Substitutes and Blood Product Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Synthetic Blood Substitutes and Blood Product Market Competition by Manufacturers
2.1 Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Manufacturers (2020-2025)
2.2 Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Synthetic Blood Substitutes and Blood Product Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Synthetic Blood Substitutes and Blood Product, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Product Type & Application
2.7 Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Date of Enter into This Industry
2.8 Global Synthetic Blood Substitutes and Blood Product Market Competitive Situation and Trends
2.8.1 Global Synthetic Blood Substitutes and Blood Product Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Synthetic Blood Substitutes and Blood Product Players Market Share by Revenue
2.8.3 Global Synthetic Blood Substitutes and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Synthetic Blood Substitutes and Blood Product Market Scenario by Region
3.1 Global Synthetic Blood Substitutes and Blood Product Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Synthetic Blood Substitutes and Blood Product Sales by Region: 2020-2031
3.2.1 Global Synthetic Blood Substitutes and Blood Product Sales by Region: 2020-2025
3.2.2 Global Synthetic Blood Substitutes and Blood Product Sales by Region: 2026-2031
3.3 Global Synthetic Blood Substitutes and Blood Product Revenue by Region: 2020-2031
3.3.1 Global Synthetic Blood Substitutes and Blood Product Revenue by Region: 2020-2025
3.3.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Region: 2026-2031
3.4 North America Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country
3.4.1 North America Synthetic Blood Substitutes and Blood Product Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Synthetic Blood Substitutes and Blood Product Sales by Country (2020-2031)
3.4.3 North America Synthetic Blood Substitutes and Blood Product Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country
3.5.1 Europe Synthetic Blood Substitutes and Blood Product Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Synthetic Blood Substitutes and Blood Product Sales by Country (2020-2031)
3.5.3 Europe Synthetic Blood Substitutes and Blood Product Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Region
3.6.1 Asia Pacific Synthetic Blood Substitutes and Blood Product Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Synthetic Blood Substitutes and Blood Product Sales by Region (2020-2031)
3.6.3 Asia Pacific Synthetic Blood Substitutes and Blood Product Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country
3.7.1 Latin America Synthetic Blood Substitutes and Blood Product Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Synthetic Blood Substitutes and Blood Product Sales by Country (2020-2031)
3.7.3 Latin America Synthetic Blood Substitutes and Blood Product Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country
3.8.1 Middle East and Africa Synthetic Blood Substitutes and Blood Product Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Synthetic Blood Substitutes and Blood Product Sales by Country (2020-2031)
3.8.3 Middle East and Africa Synthetic Blood Substitutes and Blood Product Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Synthetic Blood Substitutes and Blood Product Sales by Type (2020-2031)
4.1.1 Global Synthetic Blood Substitutes and Blood Product Sales by Type (2020-2025)
4.1.2 Global Synthetic Blood Substitutes and Blood Product Sales by Type (2026-2031)
4.1.3 Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Type (2020-2031)
4.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Type (2020-2031)
4.2.1 Global Synthetic Blood Substitutes and Blood Product Revenue by Type (2020-2025)
4.2.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Type (2026-2031)
4.2.3 Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Type (2020-2031)
4.3 Global Synthetic Blood Substitutes and Blood Product Price by Type (2020-2031)
5 Segment by Application
5.1 Global Synthetic Blood Substitutes and Blood Product Sales by Application (2020-2031)
5.1.1 Global Synthetic Blood Substitutes and Blood Product Sales by Application (2020-2025)
5.1.2 Global Synthetic Blood Substitutes and Blood Product Sales by Application (2026-2031)
5.1.3 Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Application (2020-2031)
5.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Application (2020-2031)
5.2.1 Global Synthetic Blood Substitutes and Blood Product Revenue by Application (2020-2025)
5.2.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Application (2026-2031)
5.2.3 Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Application (2020-2031)
5.3 Global Synthetic Blood Substitutes and Blood Product Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Aurum Biosciences Ltd
6.1.1 Aurum Biosciences Ltd Company Information
6.1.2 Aurum Biosciences Ltd Description and Business Overview
6.1.3 Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Product Portfolio
6.1.5 Aurum Biosciences Ltd Recent Developments/Updates
6.2 Hemarina SA
6.2.1 Hemarina SA Company Information
6.2.2 Hemarina SA Description and Business Overview
6.2.3 Hemarina SA Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Hemarina SA Synthetic Blood Substitutes and Blood Product Product Portfolio
6.2.5 Hemarina SA Recent Developments/Updates
6.3 KaloCyte Inc.
6.3.1 KaloCyte Inc. Company Information
6.3.2 KaloCyte Inc. Description and Business Overview
6.3.3 KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.3.4 KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.3.5 KaloCyte Inc. Recent Developments/Updates
6.4 NuvOx Pharma LLC
6.4.1 NuvOx Pharma LLC Company Information
6.4.2 NuvOx Pharma LLC Description and Business Overview
6.4.3 NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.4.4 NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Product Portfolio
6.4.5 NuvOx Pharma LLC Recent Developments/Updates
6.5 Northfield Laboratories
6.5.1 Northfield Laboratories Company Information
6.5.2 Northfield Laboratories Description and Business Overview
6.5.3 Northfield Laboratories Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Northfield Laboratories Synthetic Blood Substitutes and Blood Product Product Portfolio
6.5.5 Northfield Laboratories Recent Developments/Updates
6.6 Dentritech, Inc.
6.6.1 Dentritech, Inc. Company Information
6.6.2 Dentritech, Inc. Description and Business Overview
6.6.3 Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.6.5 Dentritech, Inc. Recent Developments/Updates
6.7 HemoBioTech, Inc.
6.7.1 HemoBioTech, Inc. Company Information
6.7.2 HemoBioTech, Inc. Description and Business Overview
6.7.3 HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.7.4 HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.7.5 HemoBioTech, Inc. Recent Developments/Updates
6.8 Dextro-Sang Corp.
6.8.1 Dextro-Sang Corp. Company Information
6.8.2 Dextro-Sang Corp. Description and Business Overview
6.8.3 Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.8.5 Dextro-Sang Corp. Recent Developments/Updates
6.9 Baxter International
6.9.1 Baxter International Company Information
6.9.2 Baxter International Description and Business Overview
6.9.3 Baxter International Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Baxter International Synthetic Blood Substitutes and Blood Product Product Portfolio
6.9.5 Baxter International Recent Developments/Updates
6.10 FluorO2 Therapeutics
6.10.1 FluorO2 Therapeutics Company Information
6.10.2 FluorO2 Therapeutics Description and Business Overview
6.10.3 FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.10.4 FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Product Portfolio
6.10.5 FluorO2 Therapeutics Recent Developments/Updates
6.11 Alpha Therapeutic Corp.
6.11.1 Alpha Therapeutic Corp. Company Information
6.11.2 Alpha Therapeutic Corp. Description and Business Overview
6.11.3 Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.11.5 Alpha Therapeutic Corp. Recent Developments/Updates
6.12 Hemoglobin Oxygen Therapeutics LLC
6.12.1 Hemoglobin Oxygen Therapeutics LLC Company Information
6.12.2 Hemoglobin Oxygen Therapeutics LLC Description and Business Overview
6.12.3 Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Product Portfolio
6.12.5 Hemoglobin Oxygen Therapeutics LLC Recent Developments/Updates
6.13 SpheriTech Ltd
6.13.1 SpheriTech Ltd Company Information
6.13.2 SpheriTech Ltd Description and Business Overview
6.13.3 SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.13.4 SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Product Portfolio
6.13.5 SpheriTech Ltd Recent Developments/Updates
6.14 Sangart, Inc.
6.14.1 Sangart, Inc. Company Information
6.14.2 Sangart, Inc. Description and Business Overview
6.14.3 Sangart, Inc. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sangart, Inc. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.14.5 Sangart, Inc. Recent Developments/Updates
6.15 BioPure
6.15.1 BioPure Company Information
6.15.2 BioPure Description and Business Overview
6.15.3 BioPure Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.15.4 BioPure Synthetic Blood Substitutes and Blood Product Product Portfolio
6.15.5 BioPure Recent Developments/Updates
6.16 PHORNANO Holding GmbH
6.16.1 PHORNANO Holding GmbH Company Information
6.16.2 PHORNANO Holding GmbH Description and Business Overview
6.16.3 PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.16.4 PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Product Portfolio
6.16.5 PHORNANO Holding GmbH Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Synthetic Blood Substitutes and Blood Product Industry Chain Analysis
7.2 Synthetic Blood Substitutes and Blood Product Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Synthetic Blood Substitutes and Blood Product Production Mode & Process Analysis
7.4 Synthetic Blood Substitutes and Blood Product Sales and Marketing
7.4.1 Synthetic Blood Substitutes and Blood Product Sales Channels
7.4.2 Synthetic Blood Substitutes and Blood Product Distributors
7.5 Synthetic Blood Substitutes and Blood Product Customer Analysis
8 Synthetic Blood Substitutes and Blood Product Market Dynamics
8.1 Synthetic Blood Substitutes and Blood Product Industry Trends
8.2 Synthetic Blood Substitutes and Blood Product Market Drivers
8.3 Synthetic Blood Substitutes and Blood Product Market Challenges
8.4 Synthetic Blood Substitutes and Blood Product Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Synthetic Blood Substitutes and Blood Product by Type
1.2.1 Global Synthetic Blood Substitutes and Blood Product Market Value Comparison by Type (2024 VS 2031)
1.2.2 Human Blood
1.2.3 Animal Blood
1.2.4 Microorganisms
1.2.5 Synthetic Polymers
1.2.6 Stem Cells
1.2.7 Others
1.3 Synthetic Blood Substitutes and Blood Product by Application
1.3.1 Global Synthetic Blood Substitutes and Blood Product Market Value by Application (2024 VS 2031)
1.3.2 Hospitals and Clinics
1.3.3 Blood Banks
1.3.4 Others
1.4 Global Synthetic Blood Substitutes and Blood Product Market Size Estimates and Forecasts
1.4.1 Global Synthetic Blood Substitutes and Blood Product Revenue 2020-2031
1.4.2 Global Synthetic Blood Substitutes and Blood Product Sales 2020-2031
1.4.3 Global Synthetic Blood Substitutes and Blood Product Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Synthetic Blood Substitutes and Blood Product Market Competition by Manufacturers
2.1 Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Manufacturers (2020-2025)
2.2 Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Synthetic Blood Substitutes and Blood Product Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Synthetic Blood Substitutes and Blood Product, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Product Type & Application
2.7 Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Date of Enter into This Industry
2.8 Global Synthetic Blood Substitutes and Blood Product Market Competitive Situation and Trends
2.8.1 Global Synthetic Blood Substitutes and Blood Product Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Synthetic Blood Substitutes and Blood Product Players Market Share by Revenue
2.8.3 Global Synthetic Blood Substitutes and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Synthetic Blood Substitutes and Blood Product Market Scenario by Region
3.1 Global Synthetic Blood Substitutes and Blood Product Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Synthetic Blood Substitutes and Blood Product Sales by Region: 2020-2031
3.2.1 Global Synthetic Blood Substitutes and Blood Product Sales by Region: 2020-2025
3.2.2 Global Synthetic Blood Substitutes and Blood Product Sales by Region: 2026-2031
3.3 Global Synthetic Blood Substitutes and Blood Product Revenue by Region: 2020-2031
3.3.1 Global Synthetic Blood Substitutes and Blood Product Revenue by Region: 2020-2025
3.3.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Region: 2026-2031
3.4 North America Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country
3.4.1 North America Synthetic Blood Substitutes and Blood Product Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Synthetic Blood Substitutes and Blood Product Sales by Country (2020-2031)
3.4.3 North America Synthetic Blood Substitutes and Blood Product Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country
3.5.1 Europe Synthetic Blood Substitutes and Blood Product Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Synthetic Blood Substitutes and Blood Product Sales by Country (2020-2031)
3.5.3 Europe Synthetic Blood Substitutes and Blood Product Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Region
3.6.1 Asia Pacific Synthetic Blood Substitutes and Blood Product Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Synthetic Blood Substitutes and Blood Product Sales by Region (2020-2031)
3.6.3 Asia Pacific Synthetic Blood Substitutes and Blood Product Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country
3.7.1 Latin America Synthetic Blood Substitutes and Blood Product Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Synthetic Blood Substitutes and Blood Product Sales by Country (2020-2031)
3.7.3 Latin America Synthetic Blood Substitutes and Blood Product Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country
3.8.1 Middle East and Africa Synthetic Blood Substitutes and Blood Product Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Synthetic Blood Substitutes and Blood Product Sales by Country (2020-2031)
3.8.3 Middle East and Africa Synthetic Blood Substitutes and Blood Product Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Synthetic Blood Substitutes and Blood Product Sales by Type (2020-2031)
4.1.1 Global Synthetic Blood Substitutes and Blood Product Sales by Type (2020-2025)
4.1.2 Global Synthetic Blood Substitutes and Blood Product Sales by Type (2026-2031)
4.1.3 Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Type (2020-2031)
4.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Type (2020-2031)
4.2.1 Global Synthetic Blood Substitutes and Blood Product Revenue by Type (2020-2025)
4.2.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Type (2026-2031)
4.2.3 Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Type (2020-2031)
4.3 Global Synthetic Blood Substitutes and Blood Product Price by Type (2020-2031)
5 Segment by Application
5.1 Global Synthetic Blood Substitutes and Blood Product Sales by Application (2020-2031)
5.1.1 Global Synthetic Blood Substitutes and Blood Product Sales by Application (2020-2025)
5.1.2 Global Synthetic Blood Substitutes and Blood Product Sales by Application (2026-2031)
5.1.3 Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Application (2020-2031)
5.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Application (2020-2031)
5.2.1 Global Synthetic Blood Substitutes and Blood Product Revenue by Application (2020-2025)
5.2.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Application (2026-2031)
5.2.3 Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Application (2020-2031)
5.3 Global Synthetic Blood Substitutes and Blood Product Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Aurum Biosciences Ltd
6.1.1 Aurum Biosciences Ltd Company Information
6.1.2 Aurum Biosciences Ltd Description and Business Overview
6.1.3 Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Product Portfolio
6.1.5 Aurum Biosciences Ltd Recent Developments/Updates
6.2 Hemarina SA
6.2.1 Hemarina SA Company Information
6.2.2 Hemarina SA Description and Business Overview
6.2.3 Hemarina SA Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Hemarina SA Synthetic Blood Substitutes and Blood Product Product Portfolio
6.2.5 Hemarina SA Recent Developments/Updates
6.3 KaloCyte Inc.
6.3.1 KaloCyte Inc. Company Information
6.3.2 KaloCyte Inc. Description and Business Overview
6.3.3 KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.3.4 KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.3.5 KaloCyte Inc. Recent Developments/Updates
6.4 NuvOx Pharma LLC
6.4.1 NuvOx Pharma LLC Company Information
6.4.2 NuvOx Pharma LLC Description and Business Overview
6.4.3 NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.4.4 NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Product Portfolio
6.4.5 NuvOx Pharma LLC Recent Developments/Updates
6.5 Northfield Laboratories
6.5.1 Northfield Laboratories Company Information
6.5.2 Northfield Laboratories Description and Business Overview
6.5.3 Northfield Laboratories Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Northfield Laboratories Synthetic Blood Substitutes and Blood Product Product Portfolio
6.5.5 Northfield Laboratories Recent Developments/Updates
6.6 Dentritech, Inc.
6.6.1 Dentritech, Inc. Company Information
6.6.2 Dentritech, Inc. Description and Business Overview
6.6.3 Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.6.5 Dentritech, Inc. Recent Developments/Updates
6.7 HemoBioTech, Inc.
6.7.1 HemoBioTech, Inc. Company Information
6.7.2 HemoBioTech, Inc. Description and Business Overview
6.7.3 HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.7.4 HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.7.5 HemoBioTech, Inc. Recent Developments/Updates
6.8 Dextro-Sang Corp.
6.8.1 Dextro-Sang Corp. Company Information
6.8.2 Dextro-Sang Corp. Description and Business Overview
6.8.3 Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.8.5 Dextro-Sang Corp. Recent Developments/Updates
6.9 Baxter International
6.9.1 Baxter International Company Information
6.9.2 Baxter International Description and Business Overview
6.9.3 Baxter International Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Baxter International Synthetic Blood Substitutes and Blood Product Product Portfolio
6.9.5 Baxter International Recent Developments/Updates
6.10 FluorO2 Therapeutics
6.10.1 FluorO2 Therapeutics Company Information
6.10.2 FluorO2 Therapeutics Description and Business Overview
6.10.3 FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.10.4 FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Product Portfolio
6.10.5 FluorO2 Therapeutics Recent Developments/Updates
6.11 Alpha Therapeutic Corp.
6.11.1 Alpha Therapeutic Corp. Company Information
6.11.2 Alpha Therapeutic Corp. Description and Business Overview
6.11.3 Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.11.5 Alpha Therapeutic Corp. Recent Developments/Updates
6.12 Hemoglobin Oxygen Therapeutics LLC
6.12.1 Hemoglobin Oxygen Therapeutics LLC Company Information
6.12.2 Hemoglobin Oxygen Therapeutics LLC Description and Business Overview
6.12.3 Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Product Portfolio
6.12.5 Hemoglobin Oxygen Therapeutics LLC Recent Developments/Updates
6.13 SpheriTech Ltd
6.13.1 SpheriTech Ltd Company Information
6.13.2 SpheriTech Ltd Description and Business Overview
6.13.3 SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.13.4 SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Product Portfolio
6.13.5 SpheriTech Ltd Recent Developments/Updates
6.14 Sangart, Inc.
6.14.1 Sangart, Inc. Company Information
6.14.2 Sangart, Inc. Description and Business Overview
6.14.3 Sangart, Inc. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sangart, Inc. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.14.5 Sangart, Inc. Recent Developments/Updates
6.15 BioPure
6.15.1 BioPure Company Information
6.15.2 BioPure Description and Business Overview
6.15.3 BioPure Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.15.4 BioPure Synthetic Blood Substitutes and Blood Product Product Portfolio
6.15.5 BioPure Recent Developments/Updates
6.16 PHORNANO Holding GmbH
6.16.1 PHORNANO Holding GmbH Company Information
6.16.2 PHORNANO Holding GmbH Description and Business Overview
6.16.3 PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2020-2025)
6.16.4 PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Product Portfolio
6.16.5 PHORNANO Holding GmbH Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Synthetic Blood Substitutes and Blood Product Industry Chain Analysis
7.2 Synthetic Blood Substitutes and Blood Product Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Synthetic Blood Substitutes and Blood Product Production Mode & Process Analysis
7.4 Synthetic Blood Substitutes and Blood Product Sales and Marketing
7.4.1 Synthetic Blood Substitutes and Blood Product Sales Channels
7.4.2 Synthetic Blood Substitutes and Blood Product Distributors
7.5 Synthetic Blood Substitutes and Blood Product Customer Analysis
8 Synthetic Blood Substitutes and Blood Product Market Dynamics
8.1 Synthetic Blood Substitutes and Blood Product Industry Trends
8.2 Synthetic Blood Substitutes and Blood Product Market Drivers
8.3 Synthetic Blood Substitutes and Blood Product Market Challenges
8.4 Synthetic Blood Substitutes and Blood Product Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Synthetic Blood Substitutes and Blood Product Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Synthetic Blood Substitutes and Blood Product Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Synthetic Blood Substitutes and Blood Product Market Competitive Situation by Manufacturers in 2024
Table 4. Global Synthetic Blood Substitutes and Blood Product Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Synthetic Blood Substitutes and Blood Product Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Synthetic Blood Substitutes and Blood Product Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Synthetic Blood Substitutes and Blood Product Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Synthetic Blood Substitutes and Blood Product, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Product Type & Application
Table 12. Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Synthetic Blood Substitutes and Blood Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Blood Substitutes and Blood Product as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Synthetic Blood Substitutes and Blood Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Synthetic Blood Substitutes and Blood Product Sales by Region (2020-2025) & (K Units)
Table 18. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Region (2020-2025)
Table 19. Global Synthetic Blood Substitutes and Blood Product Sales by Region (2026-2031) & (K Units)
Table 20. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Region (2026-2031)
Table 21. Global Synthetic Blood Substitutes and Blood Product Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Region (2020-2025)
Table 23. Global Synthetic Blood Substitutes and Blood Product Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Region (2026-2031)
Table 25. North America Synthetic Blood Substitutes and Blood Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Synthetic Blood Substitutes and Blood Product Sales by Country (2020-2025) & (K Units)
Table 27. North America Synthetic Blood Substitutes and Blood Product Sales by Country (2026-2031) & (K Units)
Table 28. North America Synthetic Blood Substitutes and Blood Product Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Synthetic Blood Substitutes and Blood Product Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Synthetic Blood Substitutes and Blood Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Synthetic Blood Substitutes and Blood Product Sales by Country (2020-2025) & (K Units)
Table 32. Europe Synthetic Blood Substitutes and Blood Product Sales by Country (2026-2031) & (K Units)
Table 33. Europe Synthetic Blood Substitutes and Blood Product Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Synthetic Blood Substitutes and Blood Product Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Synthetic Blood Substitutes and Blood Product Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Synthetic Blood Substitutes and Blood Product Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Synthetic Blood Substitutes and Blood Product Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Synthetic Blood Substitutes and Blood Product Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Synthetic Blood Substitutes and Blood Product Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Synthetic Blood Substitutes and Blood Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Synthetic Blood Substitutes and Blood Product Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Synthetic Blood Substitutes and Blood Product Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Synthetic Blood Substitutes and Blood Product Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Synthetic Blood Substitutes and Blood Product Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Synthetic Blood Substitutes and Blood Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Synthetic Blood Substitutes and Blood Product Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Synthetic Blood Substitutes and Blood Product Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Synthetic Blood Substitutes and Blood Product Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Synthetic Blood Substitutes and Blood Product Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Synthetic Blood Substitutes and Blood Product Sales (K Units) by Type (2020-2025)
Table 51. Global Synthetic Blood Substitutes and Blood Product Sales (K Units) by Type (2026-2031)
Table 52. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Type (2020-2025)
Table 53. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Type (2026-2031)
Table 54. Global Synthetic Blood Substitutes and Blood Product Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Synthetic Blood Substitutes and Blood Product Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Type (2020-2025)
Table 57. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Type (2026-2031)
Table 58. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Type (2020-2025)
Table 59. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Type (2026-2031)
Table 60. Global Synthetic Blood Substitutes and Blood Product Sales (K Units) by Application (2020-2025)
Table 61. Global Synthetic Blood Substitutes and Blood Product Sales (K Units) by Application (2026-2031)
Table 62. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Application (2020-2025)
Table 63. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Application (2026-2031)
Table 64. Global Synthetic Blood Substitutes and Blood Product Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Synthetic Blood Substitutes and Blood Product Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Application (2020-2025)
Table 67. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Application (2026-2031)
Table 68. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Application (2020-2025)
Table 69. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Application (2026-2031)
Table 70. Aurum Biosciences Ltd Company Information
Table 71. Aurum Biosciences Ltd Description and Business Overview
Table 72. Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Product
Table 74. Aurum Biosciences Ltd Recent Developments/Updates
Table 75. Hemarina SA Company Information
Table 76. Hemarina SA Description and Business Overview
Table 77. Hemarina SA Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Hemarina SA Synthetic Blood Substitutes and Blood Product Product
Table 79. Hemarina SA Recent Developments/Updates
Table 80. KaloCyte Inc. Company Information
Table 81. KaloCyte Inc. Description and Business Overview
Table 82. KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Product
Table 84. KaloCyte Inc. Recent Developments/Updates
Table 85. NuvOx Pharma LLC Company Information
Table 86. NuvOx Pharma LLC Description and Business Overview
Table 87. NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Product
Table 89. NuvOx Pharma LLC Recent Developments/Updates
Table 90. Northfield Laboratories Company Information
Table 91. Northfield Laboratories Description and Business Overview
Table 92. Northfield Laboratories Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Northfield Laboratories Synthetic Blood Substitutes and Blood Product Product
Table 94. Northfield Laboratories Recent Developments/Updates
Table 95. Dentritech, Inc. Company Information
Table 96. Dentritech, Inc. Description and Business Overview
Table 97. Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Product
Table 99. Dentritech, Inc. Recent Developments/Updates
Table 100. HemoBioTech, Inc. Company Information
Table 101. HemoBioTech, Inc. Description and Business Overview
Table 102. HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Product
Table 104. HemoBioTech, Inc. Recent Developments/Updates
Table 105. Dextro-Sang Corp. Company Information
Table 106. Dextro-Sang Corp. Description and Business Overview
Table 107. Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Product
Table 109. Dextro-Sang Corp. Recent Developments/Updates
Table 110. Baxter International Company Information
Table 111. Baxter International Description and Business Overview
Table 112. Baxter International Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Baxter International Synthetic Blood Substitutes and Blood Product Product
Table 114. Baxter International Recent Developments/Updates
Table 115. FluorO2 Therapeutics Company Information
Table 116. FluorO2 Therapeutics Description and Business Overview
Table 117. FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Product
Table 119. FluorO2 Therapeutics Recent Developments/Updates
Table 120. Alpha Therapeutic Corp. Company Information
Table 121. Alpha Therapeutic Corp. Description and Business Overview
Table 122. Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Product
Table 124. Alpha Therapeutic Corp. Recent Developments/Updates
Table 125. Hemoglobin Oxygen Therapeutics LLC Company Information
Table 126. Hemoglobin Oxygen Therapeutics LLC Description and Business Overview
Table 127. Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Product
Table 129. Hemoglobin Oxygen Therapeutics LLC Recent Developments/Updates
Table 130. SpheriTech Ltd Company Information
Table 131. SpheriTech Ltd Description and Business Overview
Table 132. SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Product
Table 134. SpheriTech Ltd Recent Developments/Updates
Table 135. Sangart, Inc. Company Information
Table 136. Sangart, Inc. Description and Business Overview
Table 137. Sangart, Inc. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Sangart, Inc. Synthetic Blood Substitutes and Blood Product Product
Table 139. Sangart, Inc. Recent Developments/Updates
Table 140. BioPure Company Information
Table 141. BioPure Description and Business Overview
Table 142. BioPure Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. BioPure Synthetic Blood Substitutes and Blood Product Product
Table 144. BioPure Recent Developments/Updates
Table 145. PHORNANO Holding GmbH Company Information
Table 146. PHORNANO Holding GmbH Description and Business Overview
Table 147. PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Product
Table 149. PHORNANO Holding GmbH Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Synthetic Blood Substitutes and Blood Product Distributors List
Table 153. Synthetic Blood Substitutes and Blood Product Customers List
Table 154. Synthetic Blood Substitutes and Blood Product Market Trends
Table 155. Synthetic Blood Substitutes and Blood Product Market Drivers
Table 156. Synthetic Blood Substitutes and Blood Product Market Challenges
Table 157. Synthetic Blood Substitutes and Blood Product Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Synthetic Blood Substitutes and Blood Product
Figure 2. Global Synthetic Blood Substitutes and Blood Product Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Synthetic Blood Substitutes and Blood Product Market Share by Type: 2024 & 2031
Figure 4. Human Blood Product Picture
Figure 5. Animal Blood Product Picture
Figure 6. Microorganisms Product Picture
Figure 7. Synthetic Polymers Product Picture
Figure 8. Stem Cells Product Picture
Figure 9. Others Product Picture
Figure 10. Global Synthetic Blood Substitutes and Blood Product Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Synthetic Blood Substitutes and Blood Product Market Share by Application: 2024 & 2031
Figure 12. Hospitals and Clinics
Figure 13. Blood Banks
Figure 14. Others
Figure 15. Global Synthetic Blood Substitutes and Blood Product Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Synthetic Blood Substitutes and Blood Product Market Size (2020-2031) & (US$ Million)
Figure 17. Global Synthetic Blood Substitutes and Blood Product Sales (2020-2031) & (K Units)
Figure 18. Global Synthetic Blood Substitutes and Blood Product Average Price (US$/Unit) & (2020-2031)
Figure 19. Synthetic Blood Substitutes and Blood Product Report Years Considered
Figure 20. Synthetic Blood Substitutes and Blood Product Sales Share by Manufacturers in 2024
Figure 21. Global Synthetic Blood Substitutes and Blood Product Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Synthetic Blood Substitutes and Blood Product Players: Market Share by Revenue in Synthetic Blood Substitutes and Blood Product in 2024
Figure 23. Synthetic Blood Substitutes and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Synthetic Blood Substitutes and Blood Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Synthetic Blood Substitutes and Blood Product Sales Market Share by Country (2020-2031)
Figure 26. North America Synthetic Blood Substitutes and Blood Product Revenue Market Share by Country (2020-2031)
Figure 27. United States Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Synthetic Blood Substitutes and Blood Product Sales Market Share by Country (2020-2031)
Figure 30. Europe Synthetic Blood Substitutes and Blood Product Revenue Market Share by Country (2020-2031)
Figure 31. Germany Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Synthetic Blood Substitutes and Blood Product Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Synthetic Blood Substitutes and Blood Product Revenue Market Share by Region (2020-2031)
Figure 38. China Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Synthetic Blood Substitutes and Blood Product Sales Market Share by Country (2020-2031)
Figure 48. Latin America Synthetic Blood Substitutes and Blood Product Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Synthetic Blood Substitutes and Blood Product Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Synthetic Blood Substitutes and Blood Product Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Synthetic Blood Substitutes and Blood Product by Type (2020-2031)
Figure 58. Global Revenue Market Share of Synthetic Blood Substitutes and Blood Product by Type (2020-2031)
Figure 59. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Type (2020-2031)
Figure 60. Global Sales Market Share of Synthetic Blood Substitutes and Blood Product by Application (2020-2031)
Figure 61. Global Revenue Market Share of Synthetic Blood Substitutes and Blood Product by Application (2020-2031)
Figure 62. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Application (2020-2031)
Figure 63. Synthetic Blood Substitutes and Blood Product Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Synthetic Blood Substitutes and Blood Product Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Synthetic Blood Substitutes and Blood Product Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Synthetic Blood Substitutes and Blood Product Market Competitive Situation by Manufacturers in 2024
Table 4. Global Synthetic Blood Substitutes and Blood Product Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Synthetic Blood Substitutes and Blood Product Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Synthetic Blood Substitutes and Blood Product Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Synthetic Blood Substitutes and Blood Product Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Synthetic Blood Substitutes and Blood Product, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Product Type & Application
Table 12. Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Synthetic Blood Substitutes and Blood Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Blood Substitutes and Blood Product as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Synthetic Blood Substitutes and Blood Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Synthetic Blood Substitutes and Blood Product Sales by Region (2020-2025) & (K Units)
Table 18. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Region (2020-2025)
Table 19. Global Synthetic Blood Substitutes and Blood Product Sales by Region (2026-2031) & (K Units)
Table 20. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Region (2026-2031)
Table 21. Global Synthetic Blood Substitutes and Blood Product Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Region (2020-2025)
Table 23. Global Synthetic Blood Substitutes and Blood Product Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Region (2026-2031)
Table 25. North America Synthetic Blood Substitutes and Blood Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Synthetic Blood Substitutes and Blood Product Sales by Country (2020-2025) & (K Units)
Table 27. North America Synthetic Blood Substitutes and Blood Product Sales by Country (2026-2031) & (K Units)
Table 28. North America Synthetic Blood Substitutes and Blood Product Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Synthetic Blood Substitutes and Blood Product Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Synthetic Blood Substitutes and Blood Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Synthetic Blood Substitutes and Blood Product Sales by Country (2020-2025) & (K Units)
Table 32. Europe Synthetic Blood Substitutes and Blood Product Sales by Country (2026-2031) & (K Units)
Table 33. Europe Synthetic Blood Substitutes and Blood Product Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Synthetic Blood Substitutes and Blood Product Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Synthetic Blood Substitutes and Blood Product Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Synthetic Blood Substitutes and Blood Product Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Synthetic Blood Substitutes and Blood Product Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Synthetic Blood Substitutes and Blood Product Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Synthetic Blood Substitutes and Blood Product Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Synthetic Blood Substitutes and Blood Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Synthetic Blood Substitutes and Blood Product Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Synthetic Blood Substitutes and Blood Product Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Synthetic Blood Substitutes and Blood Product Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Synthetic Blood Substitutes and Blood Product Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Synthetic Blood Substitutes and Blood Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Synthetic Blood Substitutes and Blood Product Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Synthetic Blood Substitutes and Blood Product Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Synthetic Blood Substitutes and Blood Product Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Synthetic Blood Substitutes and Blood Product Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Synthetic Blood Substitutes and Blood Product Sales (K Units) by Type (2020-2025)
Table 51. Global Synthetic Blood Substitutes and Blood Product Sales (K Units) by Type (2026-2031)
Table 52. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Type (2020-2025)
Table 53. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Type (2026-2031)
Table 54. Global Synthetic Blood Substitutes and Blood Product Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Synthetic Blood Substitutes and Blood Product Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Type (2020-2025)
Table 57. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Type (2026-2031)
Table 58. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Type (2020-2025)
Table 59. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Type (2026-2031)
Table 60. Global Synthetic Blood Substitutes and Blood Product Sales (K Units) by Application (2020-2025)
Table 61. Global Synthetic Blood Substitutes and Blood Product Sales (K Units) by Application (2026-2031)
Table 62. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Application (2020-2025)
Table 63. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Application (2026-2031)
Table 64. Global Synthetic Blood Substitutes and Blood Product Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Synthetic Blood Substitutes and Blood Product Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Application (2020-2025)
Table 67. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Application (2026-2031)
Table 68. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Application (2020-2025)
Table 69. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Application (2026-2031)
Table 70. Aurum Biosciences Ltd Company Information
Table 71. Aurum Biosciences Ltd Description and Business Overview
Table 72. Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Product
Table 74. Aurum Biosciences Ltd Recent Developments/Updates
Table 75. Hemarina SA Company Information
Table 76. Hemarina SA Description and Business Overview
Table 77. Hemarina SA Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Hemarina SA Synthetic Blood Substitutes and Blood Product Product
Table 79. Hemarina SA Recent Developments/Updates
Table 80. KaloCyte Inc. Company Information
Table 81. KaloCyte Inc. Description and Business Overview
Table 82. KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Product
Table 84. KaloCyte Inc. Recent Developments/Updates
Table 85. NuvOx Pharma LLC Company Information
Table 86. NuvOx Pharma LLC Description and Business Overview
Table 87. NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Product
Table 89. NuvOx Pharma LLC Recent Developments/Updates
Table 90. Northfield Laboratories Company Information
Table 91. Northfield Laboratories Description and Business Overview
Table 92. Northfield Laboratories Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Northfield Laboratories Synthetic Blood Substitutes and Blood Product Product
Table 94. Northfield Laboratories Recent Developments/Updates
Table 95. Dentritech, Inc. Company Information
Table 96. Dentritech, Inc. Description and Business Overview
Table 97. Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Product
Table 99. Dentritech, Inc. Recent Developments/Updates
Table 100. HemoBioTech, Inc. Company Information
Table 101. HemoBioTech, Inc. Description and Business Overview
Table 102. HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Product
Table 104. HemoBioTech, Inc. Recent Developments/Updates
Table 105. Dextro-Sang Corp. Company Information
Table 106. Dextro-Sang Corp. Description and Business Overview
Table 107. Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Product
Table 109. Dextro-Sang Corp. Recent Developments/Updates
Table 110. Baxter International Company Information
Table 111. Baxter International Description and Business Overview
Table 112. Baxter International Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Baxter International Synthetic Blood Substitutes and Blood Product Product
Table 114. Baxter International Recent Developments/Updates
Table 115. FluorO2 Therapeutics Company Information
Table 116. FluorO2 Therapeutics Description and Business Overview
Table 117. FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Product
Table 119. FluorO2 Therapeutics Recent Developments/Updates
Table 120. Alpha Therapeutic Corp. Company Information
Table 121. Alpha Therapeutic Corp. Description and Business Overview
Table 122. Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Product
Table 124. Alpha Therapeutic Corp. Recent Developments/Updates
Table 125. Hemoglobin Oxygen Therapeutics LLC Company Information
Table 126. Hemoglobin Oxygen Therapeutics LLC Description and Business Overview
Table 127. Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Product
Table 129. Hemoglobin Oxygen Therapeutics LLC Recent Developments/Updates
Table 130. SpheriTech Ltd Company Information
Table 131. SpheriTech Ltd Description and Business Overview
Table 132. SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Product
Table 134. SpheriTech Ltd Recent Developments/Updates
Table 135. Sangart, Inc. Company Information
Table 136. Sangart, Inc. Description and Business Overview
Table 137. Sangart, Inc. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Sangart, Inc. Synthetic Blood Substitutes and Blood Product Product
Table 139. Sangart, Inc. Recent Developments/Updates
Table 140. BioPure Company Information
Table 141. BioPure Description and Business Overview
Table 142. BioPure Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. BioPure Synthetic Blood Substitutes and Blood Product Product
Table 144. BioPure Recent Developments/Updates
Table 145. PHORNANO Holding GmbH Company Information
Table 146. PHORNANO Holding GmbH Description and Business Overview
Table 147. PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Product
Table 149. PHORNANO Holding GmbH Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Synthetic Blood Substitutes and Blood Product Distributors List
Table 153. Synthetic Blood Substitutes and Blood Product Customers List
Table 154. Synthetic Blood Substitutes and Blood Product Market Trends
Table 155. Synthetic Blood Substitutes and Blood Product Market Drivers
Table 156. Synthetic Blood Substitutes and Blood Product Market Challenges
Table 157. Synthetic Blood Substitutes and Blood Product Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Synthetic Blood Substitutes and Blood Product
Figure 2. Global Synthetic Blood Substitutes and Blood Product Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Synthetic Blood Substitutes and Blood Product Market Share by Type: 2024 & 2031
Figure 4. Human Blood Product Picture
Figure 5. Animal Blood Product Picture
Figure 6. Microorganisms Product Picture
Figure 7. Synthetic Polymers Product Picture
Figure 8. Stem Cells Product Picture
Figure 9. Others Product Picture
Figure 10. Global Synthetic Blood Substitutes and Blood Product Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Synthetic Blood Substitutes and Blood Product Market Share by Application: 2024 & 2031
Figure 12. Hospitals and Clinics
Figure 13. Blood Banks
Figure 14. Others
Figure 15. Global Synthetic Blood Substitutes and Blood Product Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Synthetic Blood Substitutes and Blood Product Market Size (2020-2031) & (US$ Million)
Figure 17. Global Synthetic Blood Substitutes and Blood Product Sales (2020-2031) & (K Units)
Figure 18. Global Synthetic Blood Substitutes and Blood Product Average Price (US$/Unit) & (2020-2031)
Figure 19. Synthetic Blood Substitutes and Blood Product Report Years Considered
Figure 20. Synthetic Blood Substitutes and Blood Product Sales Share by Manufacturers in 2024
Figure 21. Global Synthetic Blood Substitutes and Blood Product Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Synthetic Blood Substitutes and Blood Product Players: Market Share by Revenue in Synthetic Blood Substitutes and Blood Product in 2024
Figure 23. Synthetic Blood Substitutes and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Synthetic Blood Substitutes and Blood Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Synthetic Blood Substitutes and Blood Product Sales Market Share by Country (2020-2031)
Figure 26. North America Synthetic Blood Substitutes and Blood Product Revenue Market Share by Country (2020-2031)
Figure 27. United States Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Synthetic Blood Substitutes and Blood Product Sales Market Share by Country (2020-2031)
Figure 30. Europe Synthetic Blood Substitutes and Blood Product Revenue Market Share by Country (2020-2031)
Figure 31. Germany Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Synthetic Blood Substitutes and Blood Product Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Synthetic Blood Substitutes and Blood Product Revenue Market Share by Region (2020-2031)
Figure 38. China Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Synthetic Blood Substitutes and Blood Product Sales Market Share by Country (2020-2031)
Figure 48. Latin America Synthetic Blood Substitutes and Blood Product Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Synthetic Blood Substitutes and Blood Product Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Synthetic Blood Substitutes and Blood Product Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Synthetic Blood Substitutes and Blood Product by Type (2020-2031)
Figure 58. Global Revenue Market Share of Synthetic Blood Substitutes and Blood Product by Type (2020-2031)
Figure 59. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Type (2020-2031)
Figure 60. Global Sales Market Share of Synthetic Blood Substitutes and Blood Product by Application (2020-2031)
Figure 61. Global Revenue Market Share of Synthetic Blood Substitutes and Blood Product by Application (2020-2031)
Figure 62. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Application (2020-2031)
Figure 63. Synthetic Blood Substitutes and Blood Product Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Circuit Simulator Market Research Report 2025
Mar 11, 25
Global Schematic Editor Market Research Report 2025
Mar 11, 25
Global Milk Green Tea Market Research Report 2025
Mar 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232